| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
2 companies
Epperly Melissa B, is a Chief Financial Officer at Zentalis Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 23 sells.
Estimated insider holdings value: $2.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 2,573 | $11.44 | $29,435.12 | -0.6% | +2.2% | -81.9% | |
| Feb 2, 2024 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 8,669 | $11.54 | $100,040.26 | -1.9% | -4.1% | -85.0% | |
| Oct 4, 2023 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 5,482 | $19.50 | $106,925.60 | -0.7% | -19.7% | -83.9% | |
| Feb 14, 2023 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 7,851 | $20.13 | $158,004.52 | -1.0% | +39.7% | -40.4% | |
| Apr 4, 2022 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 17,080 | $50.09 | $855,522.43 | -1.3% | -41.3% | -66.5% | |
| Feb 23, 2022 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 1,913 | $49.10 | $93,920.75 | -0.4% | -56.5% | -59.7% | |
| Aug 19, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 9,611 | $52.00 | $499,748.14 | +1.9% | +52.2% | -49.7% | |
| Jul 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $51.27 | $158,054.33 | -0.3% | +19.3% | -43.7% | |
| Jun 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $54.05 | $166,640.95 | -0.6% | +22.1% | -55.8% | |
| May 3, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $59.24 | $182,634.73 | -0.3% | -16.5% | -55.8% |